Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3′, 5′-monophosphate (cGMP)
References (9)
- et al.
Biochem. Biophys. Res. Comm.
(1972) - et al.
J. Pharmacol. Exp. Ther.
(1977) - et al.
Naunyn-Schmiedeberg's Arch. Pharmacol.
(1976) - et al.
Nature
(1977)
There are more references available in the full text version of this article.
Cited by (8)
Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's disease
1998, Journal of the Neurological SciencesNitric oxide: A radical neurotransmitter in the central nervous system
1994, Progress in NeurobiologySudden decrease in cerebellar GABA binding induced by stress
1980, Pharmacological Research CommunicationsCerebellar pathology in schizophrenia-Cause or consequence?
1982, Neuroscience and Biobehavioral Reviews
Copyright © 1978 Published by Elsevier Inc.